Questions across 2 calls

Nitin Agarwal

DAM Capital Advisors

IPCA Laboratories Limited

IPCA Laboratories Limited CC-Dec24.pdf · 2025-02-13

Sir, on the generic business, sir, can you provide an update on How have they sort of done so far in 9 months and how are you looking at it going forward?

And then looking forward, is the U.K. business, how are you look expecting a turnaround in the business that I think is coming slower than expec we looking at the business now, sir, when you look at

Fortis Healthcare Limited

Fortis Healthcare Limited CC-Sep24.pdf · 2024-11-08

So just going back to Agilus question again. I mean, when we look forward '26, '27 onwards, can we expect the business to or do you expect the business to go back to double -digit growth trajectory?

So essentially, when you look at Agilus going forward, essentially, it's a 10% -- it's a double - digit growth business with a 25%, 26% EBITDA margin.